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OBJECTIVES The goal of this study was to prospectively examine the long-term predictive value of
brachial-artery endothelial dysfunction for future cardiovascular events.
BACKGROUND Brachial-artery endothelial function is impaired in individuals with atherosclerosis and
coronary risk factors. The prospective relation between endothelial function determined by
brachial-artery ultrasound and long-term cardiovascular risk is unknown.
METHODS We examined brachial-artery endothelial function using ultrasound in 199 patients with
peripheral arterial disease before elective vascular surgery. Patients were prospectively
followed with an average follow-up of 1.2 years after surgery.
RESULTS Thirty-five patients had an event during follow-up, including cardiac death (5 patients),
myocardial infarction (17 patients), unstable angina (10 patients), or stroke (3 patients).
Preoperative endothelium-dependent flow-mediated dilation (FMD) was significantly lower
in patients with an event (4.4  2.8%) compared with those without an event (7.0  4.9%,
p  0.001), whereas endothelium-independent vasodilation to nitroglycerin was similar in
both groups. In a Cox proportional-hazards model, independent predictors of events included
age (p 0.003), more invasive surgery (surgery other than carotid endarterectomy, p 0.02),
and impaired brachial-artery endothelial function (p  0.002). Risk was approximately
nine-fold higher in patients with FMD 8.1% (lower two tertiles) compared with those in
the upper tertile (odds ratio 9.5; 95% confidence interval 2.3 to 40).
CONCLUSIONS Impaired brachial-artery endothelial function independently predicts long-term cardiovascu-
lar events in patients with peripheral arterial disease. The findings suggest that noninvasive
assessment of endothelial function using brachial-artery FMD may serve as a surrogate end
point for cardiovascular risk. (J Am Coll Cardiol 2003;41:1769–75) © 2003 by the
American College of Cardiology Foundation
The vascular endothelium plays a central role in the regu-
lation of vascular tone, thrombosis, and inflammation
through elaboration of a number of paracrine factors that act
locally in the arterial wall (1). Endothelial dysfunction is
associated with coronary risk factors, angiographically evi-
dent coronary artery disease (CAD), and is pathophysi-
ologically linked to acute cardiovascular syndromes (2).
Recent studies have shown that impaired vasodilation as-
sessed via intra-arterial infusion of the endothelium-
dependent vasodilator acetylcholine in a coronary or periph-
eral artery identifies individuals at increased risk for future
cardiovascular disease events (3–7). However, the invasive
nature of such studies has limited the widespread clinical
application of those techniques.
Noninvasive ultrasound assessment of brachial-artery
flow-mediated dilation (FMD) has emerged as a broadly
applicable method for the study of nitric oxide-dependent
endothelial function (8,9). Brachial endothelial function is
impaired in patients with coronary disease and its risk
factors and improves in response to treatments known to
reduce cardiovascular disease risk (2). On the basis of these
findings, investigators have proposed that brachial-artery
FMD might prove useful as a surrogate marker for cardio-
vascular risk (8,10).
In support of this proposal, we previously demonstrated
that impaired brachial-artery FMD independently predicts
short-term (30-day) perioperative cardiovascular events in
patients undergoing vascular surgery (11). However, it
remains unclear whether this short-term predictive value for
perioperative events will extend to long-term spontaneous
events in these individuals after they have recovered from
the immediate stress of vascular surgery. The present study
sought to address this question by completing long-term
follow-up of vascular surgery patients who have undergone
noninvasive testing of endothelial function.
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METHODS
Patient population. Consecutive patients with peripheral
vascular disease undergoing nonemergent vascular surgery at
Boston Medical Center and the Veterans Administration
Boston Healthcare System were eligible for participation in
the study. Patients with unstable angina, recent (within one
month) myocardial infarction (MI) or stroke, decompen-
sated heart failure, or clinically significant ventricular ar-
rhythmias were excluded. All patients provided written
informed consent as approved by the institutional review
boards. We previously reported the results of 30-day
follow-up on 187 of these patients (11).
Study protocol. Up to one month before surgery, brachial-
artery reactivity was assessed as previously described (11,12).
Endothelium-dependent FMD of the brachial artery was
examined noninvasively using an established method of
high-resolution vascular ultrasound with an upper arm cuff
position. Briefly, brachial-artery two-dimensional and
pulsed Doppler flow velocity signals were obtained above
the antecubital crease with a 7.5-MHz linear array trans-
ducer using a vascular ultrasound system (140A, Toshiba
American Medical Systems, Tustin, California). Hyperemia
was induced by inflating a blood pressure cuff on the
proximal portion of the arm to occlude arterial flow (200
mm Hg) for 5 min and then rapidly deflating the cuff. After
pulse-Doppler recordings, hyperemic two-dimensional im-
ages were obtained 60 s after cuff deflation. After a 10-min
rest period to allow restoration of baseline conditions,
nonendothelium-dependent brachial-artery dilation was as-
sessed by obtaining two-dimensional images before and 3
min after administration of sublingual nitroglycerin (NTG)
(0.4 mg). Nitroglycerin was omitted if the patient refused,
had a history of migraine headaches, systolic blood pressure
100 mm Hg, previous adverse reaction to nitrates, or
critical carotid artery stenosis. An investigator blinded to
image sequence and clinical information performed off-line
analysis of digitized end-diastolic images (13).
Assessment of cardiovascular events. Patients were fol-
lowed prospectively after surgery. Cardiovascular events
were defined to include cardiac death, MI, unstable angina,
or nonhemorrhagic stroke as previously described (11,14).
In our prior study (11), serum troponin level was measured
within three days of surgery in all subjects, and we counted
troponin elevation in the absence of other clinical criteria for
MI as an event. However, routine measurement of troponin
during this long-term follow-up study was not feasible or
clinically relevant. To maintain consistency between defini-
tions of short- and long-term events in this present study,
an isolated perioperative troponin elevation in the absence
of other clinical criteria for MI was not considered an event.
Medical records were reviewed, and telephone calls were
placed to the patient or family to identify additional events
that occurred after discharge. Three cardiologists blinded to
ultrasound results adjudicated all events by review of med-
ical records. One event per patient was included in the
analysis. For patients with more than one event, the coded
event was selected using the hierarchical order listed above.
Statistical analysis. The prospectively determined primary
end point was any cardiovascular event, as defined in the
previous text. We compared FMD, NTG-mediated dila-
tion, and clinical characteristics in the groups of patients
with and without an event using the Student t test (for
continuous variables), the chi-square test (for categorical
variables), and the Fisher exact test (for categorical variables
when the expected cell count was 5). Kaplan-Meier
analysis with the log-rank test and Breslow test (weighing
the results for number of “at-risk” patients) was used to plot
and compare event-free survival distributions according to
tertile of brachial-artery FMD. A Cox proportional-hazards
model was used to control for the potentially confounding
variables that differed between patients with and without an
event using an inclusion criterion of p 0.10 (15). Potential
confounding variables were age, gender, race, diabetes
mellitus, hypertension, chronic renal insufficiency (creati-
nine 1.2 mg/dl), known coronary disease, known conges-
tive heart failure, history of smoking, history of hypercho-
lesterolemia, white blood count, hematocrit, angiotensin-
converting enzyme inhibitor therapy, beta-blocker therapy,
NTG-mediated dilation, baseline brachial-artery diameter,
extent of reactive hyperemia, and type of operation. The
noncollinear variables that met the inclusion criterion were
age, carotid surgery, FMD, diabetes mellitus, and smoking.
Because the Kaplan-Meier survival curves for the lowest and
middle tertiles of FMD overlapped and differed from the
highest tertile, patients were dichotomized in this multivar-
iate analysis as having high (upper tertile) or low (lower two
tertiles) FMD. The analyses were completed using SPSS for
Windows version 10.1 (SPSS Inc., Chicago, Illinois). Data
are presented as mean  SD.
RESULTS
Study patients. A total of 199 patients were enrolled in the
study and underwent a vascular operation, including carotid
endarterectomy (48 patients), femoral-popliteal or other
peripheral bypass (108 patients), aortic aneurysm repair (25
patients), or limb amputation (18 patients). Patients were
prospectively followed for an average of 1.2  0.8 years
(median, 390 days; range, 1 to 1,020 days). During this
follow-up period, 35 patients had a cardiovascular event
including cardiac death (5 patients), MI (17 patients),
unstable angina (10 patients), and stroke (3 patients).
Fifteen of these events occurred 30 or more days after
surgery.
Abbreviations and Acronyms
CAD  coronary artery disease
FMD  flow-mediated dilation
MI  myocardial infarction
NTG  nitroglycerin
1770 Gokce et al. JACC Vol. 41, No. 10, 2003
Endothelial Dysfunction and Events May 21, 2003:1769–75
The clinical characteristics of patients with and without
an event are displayed in Table 1. Patients with a cardio-
vascular event were older, and there were strong trends for
diabetes mellitus and more invasive surgical procedures in
patients with events.
Brachial-artery ultrasound results. For the entire group of
patients, average FMD was 6.6  4.7% (n  199), and
average NTG-mediated dilation was 10.5 6.3% (n 65).
Brachial-artery parameters for the patients with and without
a cardiovascular disease event are displayed in Table 2. As
shown, patients with an event had significantly lower FMD.
The extent of reactive hyperemia and responses to NTG
were similar in the two groups. The proportion of individ-
uals who received NTG was similar in the event (n  11,
31%) and nonevent groups (n  54, 33%). Univariate
negative correlates of FMD were larger baseline vessel
diameter (p  0.001), renal insufficiency (p  0.03), white
blood cell count (p  0.01), and diabetes mellitus (p 
0.001).
Predictive value of endothelial function. As shown in the
upper panel of Figure 1, event-free survival differed accord-
ing to tertile of FMD. Notably, the survival curves over-
lapped for the patients in the lower two tertiles. Table 3
displays the number of cardiovascular disease events when
patients are dichotomously categorized as having low FMD
(lower two tertiles, 8.1%) or high FMD (upper tertile,
8.1%), and the event-free survival curves are shown in the
middle panel in Figure 1. As shown, patients with low
FMD had significantly more events. In the Cox
proportional-hazards model, the independent predictors of
cardiovascular disease events were older age, noncarotid
surgery, and lower brachial-artery FMD (Table 4).
As shown in Figure 1, there is a large downward step in
survival resulting from a single event at 960 days, which
reflects the relatively few “at-risk” patients with this dura-
tion of follow-up. However, poor FMD remained a predic-
tor of events when the analysis was weighed by number of
“at-risk” patients (p  0.0008). Furthermore, if the analysis
is truncated to 2 years (n  163, 33 events), poor FMD
remained a predictor of events in the Kaplan-Meier analysis
(p  0.0005) and, by Cox proportional-hazards analysis,
poor FMD (p  0.005) and age (p  0.004) are indepen-
dent predictors of events.
If FMD is expressed as absolute change in diameter (a
variable that is independent of baseline diameter), rather
than as percent change in diameter, the results are similar
with impaired FMD (p  0.007), noncarotid surgery (p 
0.03), and older age (p  0.004) as the independent
predictors of events. When the subset of patients who
received NTG was analyzed separately (n  65), all 11
patients with an event had low FMD, and FMD (p  0.02)
and age (p  0.01) were independent predictors of events.
Table 1. Clinical Characteristics
No Event
(n  164)
Event
(n  35) p Value
Age (yrs) 65  11 70  10 0.005
Gender (% female) 21 31 0.17
Race (% African American) 21 20 0.25
Diabetes mellitus (%) 42 60 0.05
Hypertension (%) 68 77 0.27
Chronic renal insufficiency (%) 25 30 0.49
Known coronary disease (%) 34 40 0.47
History of heart failure (%) 6 11 0.99*
Current smoking (%) 42 26 0.07
Known hypercholesterolemia (%) 53 67 0.15
Total/HDL cholesterol 4.6  1.4 4.8  2.2 0.59
Triglycerides (mg/dl) 165  97 203  263 0.54
Creatinine (mg/dl) 1.2  1.6 1.5  1.8 0.38
White blood cell count (1,000/l) 8.5  2.9 9.0  3.3 0.37
Carotid surgery (%) 27 11 0.05
ACE inhibitor therapy (%) 37 51 0.12
Statin therapy (%) 40 49 0.33
Beta-blocker therapy (%) 45 60 0.11
Data are mean  SD or percent as indicated. *By Fisher exact test.
ACE  angiotensin-converting enzyme; HDL  high-density lipoprotein.
Table 2. Brachial Artery Parameters
No Event Event p Value
Baseline brachial diameter (mm) 3.8  0.7 4.0  0.6 0.19
Reactive hyperemia (% increase) 480  320 550  430 0.31
Flow-mediated increase in diameter (mm) 0.26  0.17 0.17  0.11 0.001
Flow-mediated dilation (%) 7.0  4.9 4.4  2.8 0.001
Nitroglycerin-mediated dilation (%) 10.9  6.5 8.8  5.3 0.32
Data are mean  SD.
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Figure 1. Kaplan-Meier plots showing survival according to brachial-artery flow-mediated dilation (FMD). The upper panel displays survival according
to tertile of FMD. Overall, survival differed according to tertile of FMD (p  0.0005). By multiple pairwise comparison, the survival curves for the lowest
and middle tertiles did not differ (p  0.87), but both differed from the highest tertile by log-rank test (p  0.0003 and p  0.0001, respectively). The
middle panel displays survival for patients in the highest tertile and for the combination of the middle and lowest tertiles. The survival curves differed by
log-rank test (p  0.0001). In the lower panel, the analysis included only those events that occurred more than 30 days after vascular surgery and displays
survival curves for patients in the highest tertile and for the combination of the middle and lowest tertiles. The survival curves differed by log-rank test (p
0.006).
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Because it could be argued that events that occur during
and immediately after vascular surgery may have a different
pathogenesis than spontaneously occurring events, we also
examined the relation between endothelial dysfunction and
cardiovascular events that developed more than 30 days after
surgery. When considering only the 15 events that took
place 30 or more days after surgery, 14 (93%) occurred in
patients with FMD 8.1%. As shown in the lower panel of
Figure 1, event-free survival differed in the highest tertile
compared with the combined middle and lowest tertiles.
After controlling for age and noncarotid surgery, endothelial
dysfunction remained an independent predictor of events
with an odds ratio of 9.6 (95% confidence interval, 1.2 to 74,
p  0.03).
DISCUSSION
This prospective study demonstrated that impaired FMD of
the brachial artery is a strong independent predictor of
cardiovascular events in patients with peripheral arterial
disease. The predictive value of FMD was independent of
the extent of reactive hyperemia and the response to an
exogenous source of nitric oxide (NTG), suggesting that the
findings are not due to variation in the stimulus for
vasodilation or the function of vascular smooth muscle.
Thus, the study supports a pathophysiologic link between
endothelial dysfunction and cardiovascular events.
Previous invasive coronary studies examined the relation
between endothelial dysfunction and cardiovascular risk.
During a 28-month follow-up of 157 patients, Suwaidi et al.
(3) demonstrated that coronary endothelial dysfunction in
the absence of obstructive lesions was associated with
increased cardiovascular events. Schachinger et al. (4) re-
ported that impaired vasodilator responses to both
endothelium-dependent and -independent agonists pre-
dicted events in 147 patients undergoing cardiac catheter-
ization over a 7.7-year follow-up period. In a study involv-
ing 308 patients with a 46-month follow-up period, Halcox
et al. (5) reported more events in patients with blunted
coronary vascular responses.
Invasive studies in the brachial artery also provide prog-
nostic information about cardiac risk. Perticone et al. (7)
reported that hypertensive patients with blunted forearm
microvascular responses to intra-arterial acetylcholine infu-
sion are more likely to experience adverse outcomes. Simi-
larly, Heitzer et al. (6) demonstrated that CAD patients
with reduced forearm dilator responses to intra-arterial
acetylcholine developed more cardiovascular events over a
4.5-year follow-up period.
Two prior studies have investigated the predictive value
of endothelial function using ultrasound-based methodol-
ogy. Neunteufl et al. (16) completed a retrospective study in
73 patients undergoing cardiac catheterization and demon-
strated that a brachial-artery FMD of 10% is associated
with increased likelihood of MI, coronary angioplasty, or
coronary bypass surgery during five-year follow-up. How-
ever, the majority of events in that study were revascular-
ization procedures, and the predictive value of endothelial
dysfunction for this outcome was lost after controlling for
extent of CAD. Finally, we recently reported that FMD
8.1% predicts short-term (within 30 days) cardiovascular
events in patients undergoing vascular surgery (11).
The present study prospectively examined the important
question of whether brachial-artery endothelial dysfunction
identifies patients at risk for spontaneously occurring events
over the long term. We found that nearly all of the events
occurred in the patients with FMD below the cut point of
8.1%. Consistent with this observation was the finding that
endothelial dysfunction had independent predictive value
even when events occurring within 30 days of surgery were
excluded from analysis.
It might be reasonable to question whether perioperative
and spontaneous events during chronic follow-up have
different pathogenic mechanisms. For example, the periop-
erative state is associated with fluid shifts, pain, and other
stresses that lead to changes in heart rate, blood pressure,
and activation of the sympathetic nervous system. Such
changes could provoke rupture of a vulnerable plaque or
increase myocardial oxygen demand to the point that it
exceeds supply in the setting of fixed coronary stenoses.
Although such changes would likely be less frequent or less
severe during chronic follow-up compared with the imme-
diate postoperative period, they still can occur during the
physical and emotional stress of normal life. Under such
circumstances, changes in blood pressure, heart rate, and
sympathetic tone would be more likely to provoke an acute
coronary syndrome or stroke if endothelial dysfunction
and/or other factors have impaired normal regulation of
vascular homeostasis. This scenario is supported by the
current findings that endothelial dysfunction predicts car-
diovascular events with both short- and long-term follow-
up.
Table 3. Numbers of Events According to FMD
FMD
p Value
Low and
Middle Tertiles
(<8.1%)
High Tertile
(>8.1%)
Number of subjects 133 66
Cardiac death 5 0 0.11
Myocardial infarction 16 1 0.01
Unstable angina 9 1 0.17
Stroke 3 0 0.55
Any event 33 2  0.001
FMD  flow-mediated dilation.
Table 4. Independent Predictors of a Postoperative Event
Odds Ratio 95% CI p Value
Low flow-mediated dilation 9.5 2.3–40 0.002
Surgery other than carotid
endarterectomy
3.4 1.2–9.7 0.02
Age (per decade) 1.7 1.2–2.4 0.003
CI  confidence interval.
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An important issue to consider is why endothelial dys-
function in the arm predicts ischemic events in remote
locations such as the coronary or carotid circulations.
Endothelial dysfunction has been proposed to be a “barom-
eter” of vascular health that integrates the overall effects of
risk factors and intrinsic defense mechanisms (10). Most
traditional coronary risk factors (e.g., hypercholesterolemia,
diabetes mellitus, hypertension) and novel risk factors (e.g.,
hyperhomocysteinemia, systemic infection, chronic inflam-
mation) are systemic in nature and might be expected to
affect vascular beds throughout the body. This concept is
supported by several studies showing that impaired FMD in
the brachial artery predicts vascular dysfunction in the
coronary circulation (17,18). The systemic nature of endo-
thelial dysfunction is also supported by studies demonstrat-
ing the predictive value of invasively determined endothelial
function in forearm resistance vessels (6,7). Thus, it is not
entirely unexpected that endothelial dysfunction detected
noninvasively in the arm has utility as a tool to assess the
generalized functional integrity of blood vessels throughout
the body (10,19,20).
One implication of the present study is the potential role
of noninvasive examination of endothelial function in the
clinical assessment of individual patients. The present find-
ing that impaired brachial-artery FMD has long-term
prognostic value suggests that the technique might be used
to frame therapeutic decisions about a particular patient’s
care, although more studies are needed before the technique
can be introduced into clinical practice. For example, it will
be important to examine larger and more diverse popula-
tions and to evaluate the relative negative and positive
predictive values of this methodology compared with other
surrogate markers for cardiovascular risk, including preop-
erative stress testing. There is currently considerable center-
to-center variation in how FMD is measured, and there is
need for a standardized approach (8,21). Although the
applicability of this methodology for individual patients
remains undefined, this present study provides strong evi-
dence for the clinical relevance of brachial-artery FMD.
Thus, the findings support the use of the methodology as a
surrogate cardiovascular end point for investigation of po-
tential new interventions in studies involving groups of
subjects.
Regarding limitations, the present study examined sub-
jects with established atherosclerosis. Thus, the results
should not be generalized to lower risk populations. In
addition, only a subset of patients received NTG, and there
was a numerical, but nonsignificant, difference in NTG-
mediated dilation between the event and no-event groups.
We cannot exclude the possibility that this difference would
have been significant with a larger sample size. However,
our finding that FMD remained an independent predictor
of events after controlling for the NTG response in this
subset of patients is consistent with a specific impairment of
endothelial function. Finally, low FMD remained an inde-
pendent predictor of events when the analysis was truncated
at two years, suggesting that the relatively modest number
of subjects with longer follow-up does not skew the results.
In summary, this prospective study of patients with
peripheral arterial disease demonstrates that brachial-artery
FMD is an independent predictor of long-term cardiovas-
cular events. The results suggest that patients with endo-
thelial dysfunction continue to have increased risk for
adverse cardiac events subsequent to the short-term stress of
vascular surgery. These findings add to the growing body of
evidence that endothelial dysfunction may contribute to the
pathogenesis of cardiovascular disease. In addition, this
study provides evidence that noninvasive assessment of
endothelial function in the brachial artery has utility as a
surrogate marker for cardiovascular disease risk.
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